INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹66 Cr | ₹66 Cr | ₹1.36 Cr | ₹4.24 Cr | ₹36 Cr |
What is the latest Contingent Liabilities ratio of INDSWIFT LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹66 Cr |
| Mar2025 | ₹66 Cr |
| Mar2024 | ₹1.36 Cr |
| Mar2023 | ₹4.24 Cr |
| Mar2022 | ₹36 Cr |
How is Contingent Liabilities of INDSWIFT LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹66 Cr | -0.11 | |
| Mar2025 | ₹66 Cr | 4,804.35 | |
| Mar2024 | ₹1.36 Cr | -68.05 | |
| Mar2023 | ₹4.24 Cr | -88.11 | |
| Mar2022 | ₹36 Cr | - | |
Compare Contingent Liabilities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹3,089.6 Cr | -1.6% | -8.1% | 240.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | -1.6% |
-8.1% |
240.3% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses